tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
:IRMD
Advertisement

Iradimed (IRMD) Stock Statistics & Valuation Metrics

Compare
158 Followers

Total Valuation

Iradimed has a market cap or net worth of $841.36M. The enterprise value is $714.43M.
Market Cap$841.36M
Enterprise Value$714.43M

Share Statistics

Iradimed has 12,715,109 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,715,109
Owned by Insiders0.77%
Owned by Institutions0.65%

Financial Efficiency

Iradimed’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.31%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)19.31%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee457.76K
Profits Per Employee120.21K
Employee Count160
Asset Turnover0.74
Inventory Turnover1.62

Valuation Ratios

The current PE Ratio of Iradimed is 41.0. Iradimed’s PEG ratio is ―.
PE Ratio41.0
PS Ratio0.00
PB Ratio0.00
Price to Fair Value8.03
Price to FCF0.00
Price to Operating Cash Flow32.32
PEG Ratio

Income Statement

In the last 12 months, Iradimed had revenue of 73.24M and earned 19.23M in profits. Earnings per share was 1.52.
Revenue73.24M
Gross Profit56.35M
Operating Income21.96M
Pretax Income24.28M
Net Income19.23M
EBITDA22.78M
Earnings Per Share (EPS)1.52

Cash Flow

In the last 12 months, operating cash flow was 26.03M and capital expenditures -12.04M, giving a free cash flow of 14.00M billion.
Operating Cash Flow26.03M
Free Cash Flow14.00M
Free Cash Flow per Share1.10

Dividends & Yields

Iradimed pays an annual dividend of $0.17, resulting in a dividend yield of 0.97%
Dividend Per Share$0.17
Dividend Yield0.97%
Payout Ratio35.96%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.73
52-Week Price Change51.35%
50-Day Moving Average58.68
200-Day Moving Average55.08
Relative Strength Index (RSI)82.42
Average Volume (3m)54.73K

Important Dates

Iradimed upcoming earnings date is Oct 31, 2025, Before Open (Confirmed).
Last Earnings DateAug 1, 2025
Next Earnings DateOct 31, 2025
Ex-Dividend DateAug 18, 2025

Financial Position

Iradimed as a current ratio of 8.84, with Debt / Equity ratio of 0.07%
Current Ratio8.84
Quick Ratio7.62
Debt to Market Cap<0.01
Net Debt to EBITDA-2.29
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Iradimed has paid 5.04M in taxes.
Income Tax5.04M
Effective Tax Rate0.21

Enterprise Valuation

Iradimed EV to EBITDA ratio is 28.30, with an EV/FCF ratio of 36.59.
EV to Sales8.80
EV to EBITDA28.30
EV to Free Cash Flow36.59
EV to Operating Cash Flow25.16

Balance Sheet

Iradimed has $50.33M in cash and marketable securities with $59.22K in debt, giving a net cash position of -$50.27M billion.
Cash & Marketable Securities$50.33M
Total Debt$59.22K
Net Cash-$50.27M
Net Cash Per Share-$3.95
Tangible Book Value Per Share$6.61

Margins

Gross margin is 76.96%, with operating margin of 29.99%, and net profit margin of 26.26%.
Gross Margin76.96%
Operating Margin29.99%
Pretax Margin33.14%
Net Profit Margin26.26%
EBITDA Margin31.11%
EBIT Margin29.99%

Analyst Forecast

The average price target for Iradimed is $71.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$71.00
Price Target Upside7.30% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast11.73%
EPS Growth Forecast10.27%

Scores

Smart Score7
AI Score77.9
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis